Search research articles
Contact Us
Filters
Showing results (141-150 of 163) with videos related to
Page
of 17
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
May 15, 1994
The role of DT-diaphorase in determining the sensitivity of human tumor cells to tirapazamine (SR 4233)
A V Patterson, N Robertson, S Houlbrook, et al.
Drug Design and Discovery
|
January 1, 1993
Synthesis of the enantiomers of the bioreductively-activated cytotoxin RSU-1069 and its prodrug RB6145 and lack of stereoselectivity in their cytotoxicity and radiosensitization in vitro
M A Naylor, M D Threadgill, H D Showalter, et al.
Anti-Cancer Drug Design
|
April 1, 1987
Mechanism of action of some bioreducible 2-nitroimidazoles: comparison of in vitro cytotoxicity and ability to induce DNA strand breakage
P O'Neill, T C Jenkins, I J Stratford, et al.
Anti-Cancer Drug Design
|
December 1, 1993
Heterocyclic mono-N-oxides with potential applications as bioreductive anti-tumour drugs: Part 1. 8-Alkylamino-substituted phenylimidazo [1,2-a] quinoxalines
M A Naylor, M A Stephens, J Nolan, et al.
Anti-Cancer Drug Design
|
April 3, 1998
5-substituted analogues of 3-hydroxymethyl-5-aziridinyl-1-methyl-2-[1H-indole-4,7-dione]prop-2-en- 1-ol (EO9, NSC 382459) and their regioisomers as hypoxia-selective agents: structure-cytotoxicity in vitro
M Jaffar, M A Naylor, N Robertson, et al.
Cancer Research
|
December 15, 1994
Induction of hypoxia in experimental murine tumors by the nitric oxide synthase inhibitor, NG-nitro-L-arginine
P J Wood, J M Sansom, S A Butler, et al.
Journal of Medicinal Chemistry
|
September 1, 1990
Synthesis and evaluation of novel electrophilic nitrofuran carboxamides and carboxylates as radiosensitizers and bioreductively activated cytotoxins
M A Naylor, M A Stephens, S Cole, et al.
British Journal of Cancer
|
May 1, 1993
Phosphomonoester is associated with proliferation in human breast cancer: a 31P MRS study
R Kalra, K E Wade, L Hands, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 15, 1994
Combination of photodynamic therapy (PDT) and melphalan in experimental tumors
J M Sansom, B Sutton, N Reeves, et al.
Anti-Cancer Drugs
|
April 1, 1995
Fused pyrazine mono-N-oxides as bioreductive drugs. III. Characterization of RB 90740 in vitro and in vivo
M A Naylor, G E Adams, A Haigh, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 163) with videos related to
Sort By:
Page
of 17
International Journal of Radiation Oncology, Biology, Physics
|
May 15, 1994
The role of DT-diaphorase in determining the sensitivity of human tumor cells to tirapazamine (SR 4233)
A V Patterson, N Robertson, S Houlbrook, et al.
Drug Design and Discovery
|
January 1, 1993
Synthesis of the enantiomers of the bioreductively-activated cytotoxin RSU-1069 and its prodrug RB6145 and lack of stereoselectivity in their cytotoxicity and radiosensitization in vitro
M A Naylor, M D Threadgill, H D Showalter, et al.
Anti-Cancer Drug Design
|
April 1, 1987
Mechanism of action of some bioreducible 2-nitroimidazoles: comparison of in vitro cytotoxicity and ability to induce DNA strand breakage
P O'Neill, T C Jenkins, I J Stratford, et al.
Anti-Cancer Drug Design
|
December 1, 1993
Heterocyclic mono-N-oxides with potential applications as bioreductive anti-tumour drugs: Part 1. 8-Alkylamino-substituted phenylimidazo [1,2-a] quinoxalines
M A Naylor, M A Stephens, J Nolan, et al.
Anti-Cancer Drug Design
|
April 3, 1998
5-substituted analogues of 3-hydroxymethyl-5-aziridinyl-1-methyl-2-[1H-indole-4,7-dione]prop-2-en- 1-ol (EO9, NSC 382459) and their regioisomers as hypoxia-selective agents: structure-cytotoxicity in vitro
M Jaffar, M A Naylor, N Robertson, et al.
Cancer Research
|
December 15, 1994
Induction of hypoxia in experimental murine tumors by the nitric oxide synthase inhibitor, NG-nitro-L-arginine
P J Wood, J M Sansom, S A Butler, et al.
Journal of Medicinal Chemistry
|
September 1, 1990
Synthesis and evaluation of novel electrophilic nitrofuran carboxamides and carboxylates as radiosensitizers and bioreductively activated cytotoxins
M A Naylor, M A Stephens, S Cole, et al.
British Journal of Cancer
|
May 1, 1993
Phosphomonoester is associated with proliferation in human breast cancer: a 31P MRS study
R Kalra, K E Wade, L Hands, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 15, 1994
Combination of photodynamic therapy (PDT) and melphalan in experimental tumors
J M Sansom, B Sutton, N Reeves, et al.
Anti-Cancer Drugs
|
April 1, 1995
Fused pyrazine mono-N-oxides as bioreductive drugs. III. Characterization of RB 90740 in vitro and in vivo
M A Naylor, G E Adams, A Haigh, et al.
Page
of 17